Improvement of the novel inhibitor for Mycobacterium enoyl-acyl carrier protein reductase (InhA): a structure-activity relationship study of KES4 assisted by in silico structure-based drug screening.

The Journal of Antibiotics
Junichi TairaShunsuke Aoki

Abstract

InhA or enoyl-acyl carrier protein reductase of Mycobacterium tuberculosis (mtInhA), which controls mycobacterial cell wall construction, has been targeted in the development of antituberculosis drugs. Previously, our in silico structure-based drug screening study identified a novel class of compounds (designated KES4), which is capable of inhibiting the enzymatic activity of mtInhA, as well as mycobacterial growth. The compounds are composed of four ring structures (A-D), and the MD simulation predicted specific interactions with mtInhA of the D-ring and methylene group between the B-ring and C-ring; however, there is still room for improvement in the A-ring structure. In this study, a structure-activity relationship study of the A-ring was attempted with the assistance of in silico docking simulations. In brief, the virtual chemical library of A-ring-modified KES4 was constructed and subjected to in silico docking simulation against mtInhA using the GOLD program. Among the selected candidates, we achieved synthesis of seven compounds, and the bioactivities (effects on InhA activity and mycobacterial growth and cytotoxicity) of the synthesized molecules were evaluated. Among the compounds tested, two candidates (compounds 3d a...Continue Reading

References

Jan 1, 1995·Annual Review of Biochemistry·P J Brennan, H Nikaido
Apr 4, 1997·Journal of Molecular Biology·G JonesR Taylor
Feb 27, 1999·Antimicrobial Agents and Chemotherapy·L M McMurryS B Levy
May 28, 2003·Journal of Chemical Information and Computer Sciences·Jean-Loup FaulonRamdas S Pophale
Mar 10, 2007·Current Topics in Medicinal Chemistry·Peter J TongeRichard A Slayden
May 15, 2010·Science·Christopher Dye, Brian G Williams
May 22, 2010·Lancet·Knut LönnrothMario C Raviglione
May 22, 2010·Lancet·Pamela Das, Richard Horton
Dec 15, 2010·Molecular Microbiology·Virginie MolleLaurent Kremer
Apr 23, 2013·Journal of Chemical Information and Modeling·Tomohiro KinjoShunsuke Aoki
Jan 13, 2015·Cold Spring Harbor Perspectives in Medicine·Giovanni SotgiuGiovanni Battista Migliori
Mar 18, 2015·European Journal of Medicinal Chemistry·Hironori KanetakaShunsuke Aoki
Oct 31, 2015·Lancet·Pamela Das, Richard Horton
Jun 1, 2017·International Journal of Mycobacteriology·Junichi TairaShunsuke Aoki

❮ Previous
Next ❯

Methods Mentioned

BETA
NMR

Software Mentioned

Molecular Operating Environment ( MOE )
GOLD
MOE
R package svmpath
gnuplot

Related Concepts

Related Feeds

Bacterial Protein Structures (ASM)

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.